Adverse reaction rates were 8.89% in the observation group and 20.00% in the control group (P > 0.05).
from: Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearaAdverse reaction rates were 8.89% in the observation group and 20.00% in the control group (P > 0.05).
from: Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearaAdverse reaction rates were 8.89% in the observation group and 20.00% in the control group (P > 0.05).
from: Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearaAdverse reaction rates were 8.89% in the observation group and 20.00% in the control group (P > 0.05).
from: Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearaThe observation group showed greater reductions in HA, PC III, and LN, and improved liver fibrosis grades (P < 0.05).